References
- Khouri RK, Cooley BC, Kunselman AR, et al. A prospective study of microvascular free-flap surgery and outcome. Plast Reconstr Surg. 1998;102:711–721.
- Rendenbach C, Holterhoff N, Hischke S, et al. Free flap surgery in Europe: an interdisciplinary survey. Int J Oral Maxillofacial Surg. 2018;47:676–682.
- Yu P, Chang DW, Miller MJ, et al. Analysis of 49 cases of flap compromise in 1310 free flaps for head and neck reconstruction. Head Neck. 2009;31:45–51.
- Hanasono MM, Kocak E, Ogunleye O, et al. One versus two venous anastomoses in microvascular free flap surgery. Plastic Reconstructive Surg. 2010;126:1548–1557.
- Nahabedian MY, Momen B, Manson PN. Factors associated with anastomotic failure after microvascular reconstruction of the breast. Plastic Reconstructive Surg. 2004;114:74–82.
- Fagien S. Extended use of botulinum toxin type a in facial aesthetic surgery. Aesthetic Surg J. 1998;18:215–219.
- Huang W, Foster JA, Rogachefsky AS. Pharmacology of botulinum toxin. J Am Acad Dermatol. 2000;43:249–259.
- Rohrich RJ, Janis JE, Fagien S, et al. The cosmetic use of botulinum toxin. Plastic Reconstructive Surg. 2003;112:177S–188S.
- Morris JL, Jobling P, Gibbins IL. Botulinum neurotoxin A attenuates release of norepinephrine but not NPY from vasoconstrictor neurons. Am J Physiol Heart Circul Physiol. 2002;283:H2627–H2635.
- Neumeister MW. The role of botulinum toxin in vasospastic disorders of the hand. Hand Clinics. 2015;31:23–37.
- Kim TK, Oh EJ, Chung JY, et al. The effects of botulinum toxin A on the survival of a random cutaneous flap. J Plastic Reconstruct Aesthetic Surg: JPRAS. 2009;62:906–913.
- Tsui JK, Hayward M, Mak EK, et al. Botulinum toxin type B in the treatment of cervical dystonia: a pilot study. Neurology. 1995;45:2109–2110.
- Dressler D, Hallett M. Immunological aspects of Botox, Dysport and Myobloc/NeuroBloc. Eur J Neurol. 2006;13:11–15.
- Clemens MW, Higgins JP, Wilgis EF. Prevention of anastomotic thrombosis by botulinum toxin a in an animal model. Plastic Reconstruct Surg. 2009;123:64–70.
- Couteau C, Rem K, Guillier D, et al. Improving free-flap survival using intra-operative heparin: Ritualistic practice or evidence-base medicine? A systematic review. Annales de Chirurgie Plastique et Esthetique. 2018;63(3):e1–e5.
- Kwok AC, Agarwal JP. An analysis of free flap failure using the ACS NSQIP database. Does flap site and flap type matter? Microsurgery. 2017;37:531–538.
- Yokoyama T, Tosa Y, Kadomatsu K, et al. A novel approach for preventing the development of persistent vasospasms after microsurgery for the extremities: intermittent topical lidocaine application. J Reconstr Microsurg. 2010;26:079–085.
- Rinkinen J, Halvorson EG. Topical vasodilators in microsurgery: what is the evidence? J Reconstr Microsurg. 2016;33:001–007.
- Van Beek AL, Lim PK, Gear AJ, et al. Management of vasospastic disorders with botulinum toxin A. Plastic Reconstruct Surg. 2007;119:217–226.
- Fathi M, Fathi H, Mazloumi M, et al. Preventive effect of botulinum toxin A in microanastomotic thrombosis: a rabbit model. J Plastic Reconstruct Aesthetic Surg: JPRAS. 2010;63:e720–e724.
- Murakami E, Iwata H, Imaizumi M, et al. Prevention of arterial graft spasm by botulinum toxin: an in-vitro experiment. Inter Cardiovasc Thoracic Surg. 2009;9:395–398.